H
Hugo M. Horlings
Researcher at Netherlands Cancer Institute
Publications - 129
Citations - 18740
Hugo M. Horlings is an academic researcher from Netherlands Cancer Institute. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 46, co-authored 106 publications receiving 15805 citations. Previous affiliations of Hugo M. Horlings include BC Cancer Agency & University of Amsterdam.
Papers
More filters
Journal ArticleDOI
LBA3 Atezolizumab with carboplatin as immune induction in metastatic lobular breast cancer: First results of the GELATO-trial
Leonie Voorwerk,Hugo M. Horlings,M.G.J. van Dongen,Karolina Sikorska,Inge Kemper,I.A.M. Mandjes,J. Van Geel,J. Boers,M. de Boer,Roberto Salgado,Gabe S. Sonke,K.E. De Visser,Ton N. Schumacher,Christian U. Blank,Agnes Jager,Carolien P. Schröder,V.C.G. Tjan-Heijnen,Sabine C. Linn,Marleen Kok +18 more
Journal ArticleDOI
Lung tumor location and lymphocyte infiltration in mice are genetically determined.
Hugo M. Horlings,Peter Demant +1 more
TL;DR: The results indicate that these qualitative phenotypes of lung tumors in mice of O20/A and OcB-9/Dem strains subjected to 2 regimens of N-ethyl-N-nitrosourea (ENU) treatment are very robust and relatively independent of environmental influences.
Journal ArticleDOI
CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
Eunyoung Kang,Ashley Weir,Nicola S. Meagher,Kyo Farrington,Gregg Nelson,Prafull Ghatage,Cheng-Han Lee,Marjorie J. Riggan,Adelyn Bolithon,Gordana C. Popovic,Betty S. Y. Leung,Katrina Tang,Neil K Lambie,Joshua Millstein,Jennifer Alsop,Michael S. Anglesio,Beyhan Ataseven,Ellen L. Barlow,Matthias W. Beckmann,Jessica Berger,Christiani Bisinotto,Hans Bösmüller,Jessica Boros,Alison Brand,Angela Brooks-Wilson,Sara Y. Brucker,Michael Carey,Yovanni Casablanca,Alicia Cazorla-Jimenez,Paul A. Cohen,Thomas P. Conrads,Linda S. Cook,Penny Coulson,Madeleine Courtney-Brooks,Daniel W. Cramer,Philip J. Crowe,Julie M. Cunningham,Cezary Cybulski,Kathleen M. Darcy,Mona El-Bahrawy,Esther Elishaev,Ramona Erber,Rhonda Farrell,Sian Fereday,Anna Fischer,María García,Simon A. Gayther,Aleksandra Gentry-Maharaj,C. Blake Gilks,M Grube,Paul R. Harnett,Shariska Petersen Harrington,Philipp Harter,Arndt Hartmann,Jonathan L. Hecht,Sebastian Heikaus,Alexander Hein,Florian Heitz,Joy Hendley,Brenda Y. Hernandez,Susanna Hernando Polo,Sabine Heublein,Akira Hirasawa,Estrid Høgdall,Claus Høgdall,Hugo M. Horlings,David G. Huntsman,Tomasz Huzarski,A. Jewell,Mercedes Jimenez-Linan,Michael Jones,Scott H. Kaufmann,Catherine J. Kennedy,Dineo Khabele,Felix K. F. Kommoss,Roy F.P.M. Kruitwagen,Diether Lambrechts,Nhu D. Le,Marcin Lener,Jenny Lester,Yee Leung,Anna-Katrine Linder,Liselore Loverix,Jan Lubinski,Rashna Madan,G. Larry Maxwell,Francesmary Modugno,Susan L. Neuhausen,Alexander B. Olawaiye,Siel Olbrecht,Sandra Orsulic,José Palacios,Celeste Leigh Pearce,Malcolm C. Pike,Carmel M. Quinn,Ganendra R. Mohan,Cristina Rodríguez-Antona,Matthias Ruebner,Andrew M. Ryan,Stuart G. Salfinger,Naoko Sasamoto,Joellen M. Schildkraut,Minouk J. Schoemaker,Mitul Shah,Raghwa Sharma,Yurii B. Shvetsov,Naveena Singh,Gabe S. Sonke,Linda Steele,Colin J.R. Stewart,Karin Sundfeldt,Anthony J. Swerdlow,Aline Talhouk,Adeline Tan,Sarah Taylor,Kathryn L. Terry,Aleksandra Toloczko,Nadia Traficante,Koen Van de Vijver,Maaike A. van der Aa,Toon Van Gorp,Els Van Nieuwenhuysen,Lilian van‐Wagensveld,Ignace Vergote,Robert A. Vierkant,Chen Wang,Lynne R. Wilkens,Stacey J. Winham,Anna H. Wu,Javier Benitez,Andrew Berchuck,Francisco José Candido dos Reis,Antoinette DeFazio,Peter A. Fasching,Ellen L. Goode,Marc T. Goodman,Jacek Gronwald,Beth Y. Karlan,Stefan Kommoss,Usha Menon,Hans-Peter Sinn,Annette Staebler,James D. Brenton,David D.L. Bowtell,Paul D.P. Pharoah,Susan J. Ramus,Martin Köbel +146 more
TL;DR: In this article , a large-scale, histotype-specific validation has been performed on CCNE1 in tubo-ovarian high-grade serous carcinoma (HGSC).
Journal ArticleDOI
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era
Benoit You,L. Van Wagensveld,Michel Tod,Gabe S. Sonke,Hugo M. Horlings,R. Kruitwagen,Andreas du Bois,Frédéric Semet,Timothy J. Perren,Jacobus Pfisterer,Florence Joly,Adrian Cook,Marie-Christine Kaminsky,K. Wollschlaeger,Alain Lortholary,Oliver Tomé,Alexandra Leary,Gilles Freyer,Maaike A. van der Aa,Olivier Colomban +19 more
TL;DR: In this article , the authors assess the likelihood of long-term disease-free (LDF) and evaluate the impact of the tumour primary chemosensitivity with respect to disease stage, and completeness of debulking surgery.
Journal ArticleDOI
57 A functional genetic approach identifies the PI3K pathway as a major determinant of Trastuzumab resistance in breast cancer
Katrien Berns,Hugo M. Horlings,Johannes B. Halfwerk,Bryan T. Hennessy,Sabine C. Linn,Michael Hauptmann,Gordon B. Mills,M.J. van de Vijver,René Bernards +8 more